AssayIndex

AX-2025-018601

N-Acetyl Semax Amide · 10 mg declared · ChinaPeptides Co., Ltd. (QYAOBIO) · lot QYB-2501-C5179

PASSVERIFIED
Report ID
AX-2025-018601
Compound
N-Acetyl Semax Amide
Compound class
Neuroactive and cognitive peptides
Supplier
QYB — ChinaPeptides Co., Ltd. (QYAOBIO)
Batch / lot
QYB-2501-C5179
Declared label claim
10mg
Laboratory
Janoshik Analytical
Assay date
19 Jun 2025
Submitted
22 Jun 2025
Quarter
2025-Q2
Submitter
a.wojcik
Sample provenance
Laboratory-retained
Section 1

Results

Measured against the index acceptance specification for the neuroactive and cognitive peptides class. A specification is a decision the index made; a result is a measurement. See where each threshold came from.

ParameterMethodResultUnitIndex spec
PurityRP-HPLC, 30 min gradient, 214 nm99.50% area≥ 98.5PASS
Total impuritiesRP-HPLC, sum of reported peaks0.50% area≤ 1.5PASS
Largest single impurityRP-HPLC — des-acetyl amide (−42 Da)0.23% area≤ 1.00PASS
Identity — theoretical monoisotopic masscalculated from molecular formula854.3806DaNOT TESTED
Identity — observed monoisotopic massLC-MS, high resolution (ESI-TOF/QTOF)854.3803DaNOT TESTED
Mass accuracyobserved vs theoretical-0.3ppm± 15PASS
Total peptide contentby difference from the gravimetric mass balance88.16%w/wNOT TESTED
Target-compound contenttotal peptide content × purity87.72%w/wNOT TESTED
Gross fill (as weighed)five-place balance, under nitrogen11.06mg10 mg declaredNOT TESTED
Recovered target peptidegross fill × target content9.702mg10 mg claimNOT TESTED
Recovery against label claimrecovered ÷ claim97.0%90.0 – 110.0PASS
Water contentKarl Fischer, coulometric, duplicate5.92%≤ 12.0PASS
Counter-ion (acetate)anion-exchange ion chromatography4.93%≤ 10.0PASS
Residual solvent + inorganic residueestimated — see /methods/residual-solvents-q3c/0.99%NOT TESTED
Endotoxinnot ordered on this submissionnot determined≤ 5.0NOT TESTED
Sterilitynot ordered on this submissionnot determinedno growthNOT TESTED
Appearancevisual, diffuse light, black and white backgroundWhite lyophilised cake, intactwhite to off-white intact cakePASS
Reconstitution clarityreconstituted per submitter procedureClear, colourless, no visible particulatesclear, no visible particulatesPASS
pH (reconstituted, 1 mg/mL)potentiometric, two-point calibration5.222.5 – 8.0PASS
Retention time (observed)RP-HPLC, 30 min gradient7.87min7.62 ± 0.25 (normalised)PASS
Peak asymmetry (10 % height)Ph. Eur. 2.2.461.290.80 – 1.50PASS
Plate count, main peakN = 5.54 (t/w½)²65,052≥ 20,000PASS
Resolution to nearest impurityvs N-acetyl semax free acid (+1 Da)1.74no index criterionREPORTED
Section 2

Chromatogram and peak integration

The figure is drawn from the table. It is not an independent illustration — if a number in the table changed, the trace would change with it.

032606520978013040 N-Acetyl Semax Amide7.87 min · 99.50 % 7.47 same trace · ×200 vertical expansion, baseline-corrected · main peak off-scale reporting threshold 0.05 % area 05101520253035 Retention time (min) Response (mAU)
Figure 1. RP-HPLC trace, 30 min gradient, 214 nm. Drawn from the peak-integration table below: peak positions are the reported retention times, peak areas are the reported area percentages, peak widths follow the reported plate count of 65,052, and skew follows the reported asymmetry factor of 1.29. Baseline noise is seeded from the report ID and is illustrative. The lower panel is the same trace at a stated vertical expansion with the slow gradient drift subtracted, because at full scale a 0.23 % impurity against a 99.50 % main peak is a line two pixels tall; the main peak runs off-scale there by design.
#PeakRTArea (µV·s)% areaΔ mass (Da)
1N-Acetyl Semax Amide — main peak7.874,836,00899.50
2des-acetyl amide (−42 Da)7.4711,1790.23-42.011
3semax (des-acetyl, des-amide, −41 Da)7.318,2630.17-41.027
4N-acetyl semax free acid (+1 Da)8.092,9160.06+0.984
5Met sulfoxide (+16 Da)7.531,9440.04+15.995
Closure check — purity + Σ impurities 100.00CLOSES

Reporting threshold 0.05 % area. Peaks below it are not reported and are therefore excluded from the total, which overstates purity by their sum — see peak integration.

Section 3

Mass spectrum and identity

Theoretical monoisotopic mass 854.3806 Da, computed from C39H54N10O10S. All ppm figures on this site are against monoisotopic values — see why that matters.

0255075100350450550650750850950 [M+1H]1+855.39[M+2H]2+428.20 m/z Relative abundance (%)
Figure 2. ESI charge-state envelope, high-resolution instrument. Sticks are placed at m/z = (M + z × 1.007276)/z for the observed neutral mass of 854.3803 Da. Sodium (+21.982/z) and potassium (+37.956/z) adducts are shown where the parent charge state exceeds 25 % relative abundance; they are adducts of the same molecule and are not impurities.
ChargeTheoretical m/zObserved m/zΔ m/zRel. abundance (%)
2+428.1976428.1974-0.000256.3
1+855.3879855.3876-0.0003100.0
Section 4

Gravimetric mass balance

Water, counter-ion, residual and total peptide content are exhaustive and mutually exclusive categories. They must account for 100 % of the cake mass. The index closes this to within 0.02 pp and the build asserts it.

ComponentDetermination%w/w of cake
WaterKarl Fischer5.92
Counter-ion (acetate)ion chromatography4.93
Residual solvent + inorganic residueestimated0.99
Total peptide contentby difference88.16
Total100.00 CLOSES

Supplier certificate, as declared

The supplier's own figures for this lot, beside the independent measurement. Divergence is assessed against the batch median, not against this single report — see rule AX-R05.

FigureSupplier COAThis reportIndex note
Purity (% area)99.1799.50divergence -0.55 pp vs batch median
Total impurities (% area)0.830.50
Largest single impurity (% area)not stated0.23
Water (%)not stated5.92
Counter-ion (%)not stated4.93
Peptide content (%w/w)not stated88.16
Endotoxin (EU/mg)0.40not determined
Method stated on certificateYEScolumn, gradient and wavelength given
Section 5

Provenance and caveats

Where a sample came from changes the weight of the evidence. The index treats it as a first-class field.

Sample provenance
Laboratory-retained
Evidentiary weight
Provenance documented, selection uncontrolled.
Chain of custody
Laboratory retained sample (−20 °C, 2 d since original receipt) → re-assay.
Assay date
19 Jun 2025
Submitted to the index
22 Jun 2025
Laboratory
Janoshik Analytical, Ostrava, Czechia
Method basis
30 min gradient · high-resolution MS
Verification status
VERIFIED
Section 6

Annotations 2

Signed technical comments from index contributors. Not a discussion forum — annotations question or contextualise the result, and the data team replies where a reply is warranted.

ms_confirm
A reference standard on the same sequence would upgrade this from a good mass to a traceable one. The distinction matters where a result is going to be cited rather than merely read.
esi_tof
An orthogonal identity method on the same lot would make this the strongest class of record the index holds. Mass plus retention is already better than most.
Section 7

Related records

Same batch — lot QYB-2501-C5179 n=9

ReportLotLabQuarterPurity %Water %Recovery %ProvenanceFlagsResult
AX-2025-018602QYB-2501-C5179Nordanalyt2025-Q299.936.04Laboratory-retained0PASS
AX-2025-018603QYB-2501-C5179Janoshik2025-Q299.686.1397.9Laboratory-retained0PASS
AX-2025-018604QYB-2501-C5179Kestrel2025-Q299.716.34Buyer-sourced0PASS
AX-2025-018605QYB-2501-C5179PeptideMeter2025-Q299.646.32Buyer-sourced0PASS
AX-2025-018606QYB-2501-C5179Kestrel2025-Q299.936.1098.7Buyer-sourced0PASS
AX-2025-018607QYB-2501-C5179Medutest2025-Q299.935.93102.3Buyer-sourced0PASS
AX-2025-018608QYB-2501-C5179Janoshik2025-Q299.726.56Buyer-sourced1MARGINAL
AX-2025-018609QYB-2501-C5179Janoshik2025-Q299.936.0294.2Buyer-sourced0PASS
Other recent N-Acetyl Semax Amide records in the index.
ReportSupplierLotLabQuarterPurity %Water %Recovery %ProvenanceFlagsResult
AX-2026-043327CPCCPC-2602-D1905Nordanalyt2026-Q399.055.6790.6Buyer-sourced1FAIL
AX-2026-043328CPCCPC-2602-D1905Janoshik2026-Q399.496.83100.9Supplier-supplied0PASS
AX-2026-043331CPCCPC-2602-D1905Janoshik2026-Q399.466.22Supplier-supplied0PASS
AX-2026-043329CPCCPC-2602-D1905Janoshik2026-Q398.565.44Buyer-sourced0PASS
AX-2026-043330CPCCPC-2602-D1905Janoshik2026-Q398.655.7091.4Laboratory-retained0PASS
AX-2026-043326CPCCPC-2602-D1905VendorInvestigate2026-Q398.935.74107.0Buyer-sourced0PASS
AX-2026-042484HomopeptideHOMO-2603-C5267Janoshik2026-Q299.178.6192.1Buyer-sourced0PASS
AX-2026-042488HomopeptideHOMO-2603-C5267PeptideMeter2026-Q298.838.48Buyer-sourced0PASS
Other recent QYB records in the index.
ReportCompoundLotLabQuarterPurity %Water %Recovery %ProvenanceFlagsResult
AX-2026-041471PT-141 (Bremelanotide)QYB-2607-L4875Janoshik2026-Q399.723.75101.7Buyer-sourced0PASS
AX-2026-041377IpamorelinQYB-2605-H3558Nordanalyt2026-Q399.934.35Buyer-sourced0PASS
AX-2026-041427RetatrutideQYB-2604-B4920PeptideMeter2026-Q397.932.45101.7Buyer-sourced0PASS
AX-2026-041428RetatrutideQYB-2604-B4920Janoshik2026-Q398.353.20Laboratory-retained0PASS
AX-2026-041473PT-141 (Bremelanotide)QYB-2607-L4875PeptideMeter2026-Q399.583.7494.4Buyer-sourced0PASS
AX-2026-041472PT-141 (Bremelanotide)QYB-2607-L4875PeptideMeter2026-Q399.933.94Buyer-sourced0PASS
AX-2026-041429RetatrutideQYB-2604-B4920Medutest2026-Q398.532.6999.8Buyer-sourced1MARGINAL
AX-2026-041431RetatrutideQYB-2604-B4920Janoshik2026-Q398.632.3294.2Buyer-sourced0PASS